$2.30
0[0.00%]
At close: Apr 18
$2.30
0[0.00%]
After Hours: 4:00PM EDT
VYNE Therapeutics
(NASDAQ:VYNE)VYNE Therapeutics Stock (NASDAQ:VYNE), Earnings Estimates, EPS, and Revenue
VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.240
Quarterly Revenue Estimate
$100K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$424K
Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | VYNE | Q1 | -$1.48 | -$0.24 | — | — | $99.00K | $100.00K | — | — | Get Alert |
| 02/29/2024 | AM | VYNE | Q4 | -$2.97 | -$0.50 | -$0.18 | 64.00% | $6.00K | $150.00K | $76.00K | -49.33% | Get Alert |
| 11/13/2023 | AM | VYNE | Q3 | -$2.52 | -$1.97 | -$1.75 | 11.17% | $167.00K | — | $114.00K | — | Get Alert |
| 08/14/2023 | PM | VYNE | Q2 | -$2.34 | -$1.99 | -$2.82 | -41.71% | $126.00K | $100.00K | $135.00K | 35.00% | Get Alert |
| 05/11/2023 | PM | VYNE | Q1 | $1.80 | -$2.61 | -$1.48 | 43.30% | $178.00K | — | $99.00K | — | Get Alert |
| 03/09/2023 | PM | VYNE | Q4 | -$3.60 | -$3.24 | -$2.97 | 8.33% | $2.29M | $60.00K | $6.00K | -90.00% | Get Alert |
| 11/10/2022 | PM | VYNE | Q3 | -$7.38 | -$3.06 | -$2.52 | 17.65% | $4.09M | $130.00K | $167.00K | 28.46% | Get Alert |
| 08/12/2022 | AM | VYNE | Q2 | -$6.30 | -$3.06 | -$2.34 | 23.53% | $4.26M | $100.00K | $126.00K | 26.00% | Get Alert |
| 05/12/2022 | PM | VYNE | Q1 | -$3.96 | -$2.88 | $1.80 | 162.50% | $230.00K | $370.00K | $178.00K | -51.89% | Get Alert |
| 03/17/2022 | AM | VYNE | Q4 | -$7.74 | -$4.32 | -$3.60 | 16.67% | $4.29M | $4.12M | $2.29M | -44.37% | Get Alert |
| 11/10/2021 | AM | VYNE | Q3 | -$9.36 | -$5.76 | -$6.48 | -12.50% | $3.27M | $4.76M | $4.09M | -14.16% | Get Alert |
| 08/12/2021 | AM | VYNE | Q2 | -$3.28 | -$6.30 | -$6.30 | 0.00% | $11.69M | $6.21M | $4.26M | -31.43% | Get Alert |
| 05/06/2021 | AM | VYNE | Q1 | -$3.80 | -$7.38 | -$6.66 | 9.76% | — | $5.31M | $4.12M | -22.43% | Get Alert |
| 03/04/2021 | AM | VYNE | Q4 | -$3.56 | -$9.54 | -$7.74 | 18.87% | — | $4.71M | $4.29M | -9.00% | Get Alert |
| 11/05/2020 | AM | VYNE | Q3 | -$2.80 | -$12.24 | -$9.36 | 23.53% | — | $3.25M | $3.27M | 0.58% | Get Alert |
| 08/06/2020 | AM | VYNE | Q2 | -$2.76 | -$1.00 | -$3.28 | -228.00% | — | $2.42M | $11.69M | 382.98% | Get Alert |
| 05/11/2020 | AM | VYNE | Q1 | -$3.24 | -$2.16 | -$3.80 | -75.93% | — | $2.18M | $1.75M | -19.72% | Get Alert |
| 03/03/2020 | PM | VYNE | Q4 | -$3.04 | — | -$3.56 | — | — | — | $0.00 | — | Get Alert |
| 10/31/2019 | PM | VYNE | Q3 | -$2.24 | — | -$2.80 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics (VYNE) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?
The Actual EPS was $-0.18, which beat the estimate of $-0.50.
What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?
The Actual Revenue was $76K, which missed the estimate of $150K.
Browse earnings estimates, EPS, and revenue on all stocks.